EBS Earnings

Quarterly EPS
$2.16
Q3 2024
$-0.58
Q4 2024
$1.25
Q1 2025
$-0.22
Q2 2025
$0.96
Q3 2025
$-1.05
Q4 2025
$0.13
Q1 2026
$-3.49
Q2 2026
Latest Revenue234.3M
Latest Net Income-180200000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.49234.3M-180200000+66.3%-1,486.4%
Q1 2026$0.13156.1M6.8M-29.7%-89.6%
Q4 2025-$1.05148.7M-54600000-23.6%-81.0%
Q3 2025$0.96231.1M51.2M-21.3%-55.6%
Q2 2025-$0.22140.9M-12000000-44.7%+95.9%
Q1 2025$1.25222.2M68.0M-26.0%+635.3%
Q4 2024-$0.58194.7M-31300000-29.6%+38.9%
Q3 2024$2.16293.8M114.8M+8.6%+142.5%
Q2 2024-$5.38254.7M-283100000
Q1 2024$0.17300.4M9.0M
Q4 2023-$0.95276.6M-49500000
Q3 2023-$5.08270.5M-263400000
Emergent Biosolutions (EBS) — Earnings